600566 济川药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.70412.13218.04922.86921.226
总资产报酬率 ROA (%)2.2529.83313.83217.04316.013
投入资产回报率 ROIC (%)2.51511.26516.38720.82219.532

边际利润分析
销售毛利率 (%)82.12478.95579.25081.52282.911
营业利润率 (%)39.17634.69835.71133.74726.939
息税前利润/营业总收入 (%)35.90033.89434.14631.48426.924
净利润/营业总收入 (%)33.04928.59631.64229.28224.140

收益指标分析
经营活动净收益/利润总额(%)78.98688.22188.24895.17794.725
价值变动净收益/利润总额(%)9.49310.6936.1362.9222.348
营业外收支净额/利润总额(%)0.2370.2083.8731.1813.366

偿债能力分析
流动比率 (X)5.4584.9314.1553.1003.261
速动比率 (X)5.3164.8233.9942.9933.147
资产负债率 (%)15.82217.33120.22326.31724.222
带息债务/全部投入资本 (%)6.1975.3536.4829.5954.995
股东权益/带息债务 (%)1,494.0971,745.0441,423.752929.4521,868.877
股东权益/负债合计 (%)531.093476.123393.828279.579312.426
利息保障倍数 (X)-10.657-38.680-11.367-11.805-28.242

营运能力分析
应收账款周转天数 (天)117.624122.177110.015103.62798.903
存货周转天数 (天)141.620120.862114.60588.94689.808